Literature DB >> 29439039

Complete Genome Sequence of the Myoviral Bacteriophage YS35, Which Causes the Lysis of a Multidrug-Resistant Pseudomonas aeruginosa Strain.

Sheng Yu1, Honglan Huang1, Yuchong Hao1, Hongyan Shi1, Chunyan Zhao1, Yanbo Sun2.   

Abstract

The lytic bacteriophage YS35, which is capable of lysing multidrug-resistant Pseudomonas aeruginosa strains, was isolated from a sewage sample. Here, we describe the complete genome sequence of this myoviral bacteriophage, which contains 93,296 bp of double-stranded DNA and has a 49.4% G+C content.
Copyright © 2018 Yu et al.

Entities:  

Year:  2018        PMID: 29439039      PMCID: PMC5805877          DOI: 10.1128/genomeA.01395-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Pseudomonas aeruginosa strains are glucose-nonfermenting Gram-negative opportunistic pathogens that cause health care-associated infections (1). Moreover, the growing prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) P. aeruginosa strains is considered a tremendous threat to global public health (2, 3). Recently, the application of phage-based products to treat P. aeruginosa infections in vitro and in vivo has been reported (4). We isolated the lytic bacteriophage YS35 from a sewage sample collected at the First Affiliated Hospital of Jilin University, China, using the MDR P. aeruginosa strain DH35 isolated from a patient with chronic pulmonary infection. The bacteriophage YS35 belongs to the Myoviridae family based on the morphological features determined using transmission electron microscopy. Genomic DNA of phage YS35 was extracted from purified phage stock using a phenol extraction method (5). Whole-genome sequencing was conducted using the Illumina HiSeq 4000 platform at Hangzhou Lianchuan Biotechnology Co., Ltd. (Hangzhou, China). Quality-controlled trimmed reads were assembled with MITObim version 1.8 software. The coverage was on the order of 1,000×, and one contig was obtained. Potential open reading frames (ORFs) were identified with GeneMarkS version 4.17 (6), and the functions of the ORFs were predicted using BLASTp searches against the nonredundant NCBI database. tRNAscan-SE version 1.3.1 (7) was employed to predict tRNAs. The YS35 genome comprises 93,296 bp of linear double-stranded DNA with a G+C content of 49.3% and 13 tRNAs. In total, 172 ORFs were predicted, only 28 of which had a putative function. Furthermore, 52 ORFs are rightward oriented, while 120 ORFs are leftward oriented. According to a BLASTn analysis, the nearest neighbors (query coverage range from 95% to 97%, identity range from 98% to 99%) of phage YS35 are Pseudomonas phages vB_PaeM C2-10 Ab02, phage vB_PaeM C2-10 Ab10, phage vB_PaeM C2-10 Ab1, phage vB_PaeM C2-10 Ab8, and phage vB_PaeM C2-10 Ab15. These five phages, which were isolated in Abidjan, Côte d’Ivoire, are similar to PAK_P1, which was isolated in France. Therefore, the phage YS35 is closely associated with PAK_P1-like virus. The comprehensive analysis of the genes and proteins encoded by phage YS35 can provide new insight into phage-bacteria coevolution and strategies for the therapeutic use of bacteriophages.

Accession number(s).

The complete genome sequence of bacteriophage YS35 has been deposited in GenBank under accession number MF974178.
  6 in total

1.  GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions.

Authors:  J Besemer; A Lomsadze; M Borodovsky
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

2.  tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence.

Authors:  T M Lowe; S R Eddy
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

Review 3.  Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.

Authors:  Diana P Pires; Diana Vilas Boas; Sanna Sillankorva; Joana Azeredo
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

Review 4.  Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.

Authors:  Marilee D Obritsch; Douglas N Fish; Robert MacLaren; Rose Jung
Journal:  Pharmacotherapy       Date:  2005-10       Impact factor: 4.705

5.  Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.

Authors:  C Peña; S Gómez-Zorrilla; C Suarez; M A Dominguez; F Tubau; O Arch; A Oliver; M Pujol; J Ariza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-04       Impact factor: 3.267

Review 6.  Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.

Authors:  Michael Buhl; Silke Peter; Matthias Willmann
Journal:  Expert Rev Anti Infect Ther       Date:  2015-07-07       Impact factor: 5.091

  6 in total
  2 in total

1.  Characterization of a novel bullet-shaped lytic bacteriophage against extensively drug-resistant Pseudomonas aeruginosa isolated from human and domestic sources.

Authors:  Mohadeseh Barazandeh; Khashayar Shahin; Abolghasem Hedayatkhah; Majid Komijani; Mojtaba Mansoorianfar
Journal:  Vet Res Forum       Date:  2021-12-15       Impact factor: 0.950

2.  Identification and characterization of phage protein and its activity against two strains of multidrug-resistant Pseudomonas aeruginosa.

Authors:  Fairoz Al-Wrafy; Ewa Brzozowska; Sabina Górska; Marek Drab; Magdalena Strus; Andrzej Gamian
Journal:  Sci Rep       Date:  2019-09-17       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.